Chemical formula: C₁₅H₁₁I₃NaNO₄ Molecular mass: 650.974 g/mol PubChem compound: 5920
Liothyronine sodium is a naturally occurring thyroid hormone. The biological action of liothyronine sodium is quantitatively similar to that of levothyroxine sodium.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| H03AA02 | Liothyronine sodium | H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| IRAKSIN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| CYTOMEL Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Liothyronine is an active ingredient of these brands:
Australia (AU)
Austria (AT)
Canada (CA)
Estonia (EE)
Japan (JP)
Mexico (MX)Netherlands (NL)
Poland (PL)
Romania (RO)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
